Financial Analysis

NOTE 11 COMMITMENTS AND CONTINGENCIES As of April 30, 2026 and 2025, the Company has no commitments or contingencies. …

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

Schedule of disaggregated revenue For the Years ended April 30, Type of products or services Timing of revenue recognition 2026 2025 Other Services transferred over time $ 15,000 $ 10,838 Sales of dietary supplement Goods transferred at a point in time 1,947,620 2,651,267 Sales of food products Goods transferred at a point in time 1,062,918 TOTAL $ 3,025,538 $ 2,662,105 …

DisaggregationOfRevenueTableTextBlock · excerpt; the full note is in the filing

NOTE 7 - INCOME TAX EXPENSE The Company and its subsidiaries are subject to 21% federal corporate income tax rate in US and 6.5% New York state corporate income tax rate. The income tax provision for the years ended April 30, 2026 and 2025, consists of the following: Schedule of income tax provision Years ended April 30, 2026 2025 Federal Current $ 5,382 $ 310,699 Deferred (12,887 ) State Current 54,091 42,859 Deferred (3,151 ) Income tax provision $ 43,885 $ 353,558 As of April 30, 2026 and 2025, the Companys net deferred tax assets are as follows: Schedule of deferred tax assets As of April 30, 2026 2025 Deferred tax assets: Net operating loss $ $ 102,611 Bad debt expense 16,038 Total deferred tax assets 16,038 102,611 Less: valuation allowance (102,611 ) Deferred tax assets, net $ 16,038 $ The valuation allowance for deferred tax assets as of April 30, 2026 and 2025 was $ 0 and $ 102,611 , respectively. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on consideration of these …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

Recently Issued Accounting Pronouncements In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements Codification Amendments in Response to the SECs Disclosure Update and Simplification Initiative. The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SECs August 2018 final amendments in Release No. 33-10532, Disclosure Update and Simplification that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. Early adoption is permitted. The adoption of ASU 2023-06 is not expected to have a material impact on the Companys consolidated financial statements or related disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03 …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

NOTE 9 RELATED PARTY BALANCES AND TRANSACTIONS Nature of relationships with related parties Name of related party Relationship with the Company Rose Kelly (Ms. Kelly) Chief Executive Officer and Director of the Company Robert M. Kelly (Mr. Robert) Family member of Ms. Kelly Steve Niu (Mr. Niu) Chief Financial Officer of the Company On January 8, 2024, the Company granted 1,667 common stocks issuable per month in total of 20,000 common stocks to the Chief Financial Officer - Steve Niu, at fair value of $0.15 per share, subject to vesting conditions in completion of one year of service. For the years ended April 30, 2026 and 2025, the Company recognized share-based compensation in the amount of $ 0 and $ 2,000 , respectively. As of April 30, 2026 and 2025, the Companys common stock issuable under share-based compensation totaling $ 3,000 for 20,000 shares. During the year ended April 30, 2026 and 2025, Mr. Robert received compensation of $ 12,000 and $ 0 for his service. During the year ended April 30, 2026 and 2025, Ms. Kelly received compensation of $ 59,733 and $ 134,283 for her service. During the year ended April 30, 2026 and 2025, Mr. Niu received compensation of $ 24,000 and $ 8,000 for his service. …

RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 3 SEGMENT REPORTING Currently, the Company has two reportable business segments: sale and distribution of dietary supplement and wholesale and trading of food products segment. In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments. Schedule of reconciliation of the disaggregated revenues Years ended April 30, 2026 Healthy Food Products Dietary Supplement Other Total Revenue from external customers: Consulting service income $ $ $ 15,000 $ 15,000 Sale of dietary supplement products 1,947,620 1,947,620 Sale of healthy food products 1,062,918 1,062,918 Total revenue 1,062,918 1,947,620 15,000 3,025,538 Cost of revenue: Consulting service income Sale of dietary supplement products (1,147,934 ) (1,147,934 ) Sale of healthy food products (967,015 ) (967,015 ) Total cost of revenue (967,015 ) (1,147,934 ) (2,114,949 ) Gross profit 95,903 799,686 15,000 910,589 Operating Expenses: Sales and distribution expenses (2,900 ) (2,900 ) Personal and benefit costs (43,591 ) (126,702 ) (170,293 ) General and administrative (231,778 ) (502,017 ) (733,795 ) Total operating expenses (275,369 ) (631,619 ) (906,988 ) Segment income (loss) $ (179,466 ) $ 168,067 $ 15,000 $ 3,601 For the Year ended April 30, 2025 Dietary Supplement Segment Consulting Service Segment Total Revenue from external customers: Consulting service income $ $ 10,838 $ 10,838 Sale of dietary supplement products …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the SEC). The financial statements are presented in US dollars, which is the Companys functional currency. Principles of Consolidation The consolidated financial statements include the financial statements of the Company and its subsidiary. All significant inter-company balances and transactions within the Company have been eliminated upon consolidation. Use of Estimates and Assumptions The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. These estimates and judgments include, but are not limited to, revenue recognition, allowance for credit losses, inventory impairment allowance, and deferred taxes. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Although actual amou …

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

NOTE 8 SHAREHOLDERS EQUITY Preferred Stock The Company is authorized to issue 10,000,000 shares of preferred stock, par value $ 0.001 per share, of which 3,000,000 shares of preferred stock have been designated as Series A Preferred Stock. Each share of Series A Preferred Stock shall entitle the holder to cast 20 votes, which votes shall be identical in all respects to, and counted on the same bases as, votes of shares of common stock and included in the totals for the common stock. Each share of Series A Preferred Stock is convertible at the option of the holder at any time into one share of common stock. The holders of Series A Preferred Stock shall not be entitled to receive dividends of any kind or be entitled to any liquidation preference. As of April 30, 2026 and 2025, no preferred stock has been issued and outstanding. Common Stock The Company is authorized to issue 200,000,000 shares of common stock, par value $ 0.001 per share, As of April 30, 2026 and 2025, 8,337,454 common stocks are issued and outstanding. On January 27, 2026, the Company's 1-for-3 reverse stock split of its common stock became effective, pursuant to which each holder of common stock received one share for every three shares held. The accompanying consolidated financial statements were retroactively reflected the reverse stock split for the periods presented. On January 8, 2024, the Company granted 1,667 common stocks issuable per month in total of 20,000 common stocks to the Chief Financial Offic …

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 12 SUBSEQUENT EVENTS In accordance with ASC Topic 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after April 30, 2026, up to the date that the consolidated financial statements were available to be issued. …

SubsequentEventsTextBlock · excerpt; the full note is in the filing

NOTE 9 - COMMITMENTS AND CONTINGENCIES As of October 31, 2025, the Company has no commitments or contingencies.

CommitmentsAndContingenciesDisclosureTextBlock

Schedule of disaggregated revenue For the three months ended October 31, For the six months ended October 31, Type of products or services Timing of revenue recognition 2025 2024 2025 2024 Consultancy service fee income Services transferred over time $ 6,489 $ 3,838 $ 10,714 $ 3,838 Sales of dietary supplement products Goods transferred at a point in time 420,626 288,280 520,300 396,757 Total $ 427,115 $ 292,118 $ 531,014 $ 400,595

DisaggregationOfRevenueTableTextBlock

NOTE 6 - INCOME TAX EXPENSE The income tax provision for the six months ended October 31, 2025 and 2024, consists of the following: Schedule of income tax provision Six Months ended October 31, 2025 2024 Federal Current $ 59,357 $ 35,459 Deferred 2,466 State Current 17,984 Deferred Income tax provision $ 77,341 $ 37,925 The deferred tax assets as of October 31, 2025 and April 30, 2025 were $ 147,929 and $ 102,611 , respectively, which were fully reserved for valuation allowance. The net change in valuation allowance as of October 31, 2025 and April 30, 2025 was $ 45,318 . In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of October 31, 2025 and April 30, 2025. Up to six years since inception remain open for examination only by taxing authorities of US Federal and St …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

Recent Accounting Standard Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amended guidance requires incremental reportable segment disclosures, primarily about significant segment expenses. The amendments also require entities with a single reportable segment to provide all disclosures required by these amendments, and all existing segment disclosures. The amendments will be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted this amended guidance on May 1, 2025 and concluded there is no significant impact on the footnotes to its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires disclosure of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state, and foreign taxes. It also requires disaggregating individ …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

NOTE 7 - RELATED PARTY BALANCES AND TRANSACTIONS Nature of relationships with related parties Name of related party Relationship with the Company Qiuping Lu (Ms. Lu) Chief Executive Officer and Director of the Company Steve Niu (Mr. Niu) Chief Financial Officer of the Company On January 8, 2024, the Company granted 5,000 common stocks issuable per month in total of 60,000 common stocks to the Chief Financial Officer - Steve Niu, at fair value of $0.05 per share, subject to vesting condition in completion of one year of service. For the six months ended October 31, 2025 and 2024, the Company recognized share-based compensation in the amount of $ Nil and $ 1,750 , respectively. As of October 31, 2025 and April 30, 2025, the Companys common stock issuable under share-based compensation totaled $ 3,000 for 60,000 shares. …

RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 3 SEGMENT REPORTING Currently, the Company has two reportable business segments: (i) Consulting Service Segment, mainly provides consulting advisory services in management business, accounting and financial services; and (ii) Dietary supplement Segment, mainly provides dietary supplement products. In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments. Schedule of reconciliation of the disaggregated revenues Three Months ended October 31, 2025 Dietary Supplement Segment Consulting Service Segment Total Revenue from external customers: Consulting service income $ $ 6,489 6,489 Sale of dietary supplement products 420,626 420,626 Total revenue 420,626 427,115 Cost of revenue: Consulting service income Sale of dietary supplement products (166,312 ) (166,312 ) Total cost of revenue (166,312 ) (166,312 ) Gross profit 254,314 6,489 260,803 Operating Expenses Sales and distribution expenses (2,900 ) (2,900 ) Personal and benefit costs (11,739 ) (27,549 ) (39,289 ) General and administrative (7,546 ) (111,899 ) (119,444 ) Total operating expenses (22,185 ) (139,448 ) (161,633 ) Segment income (loss) $ 232,129 $ (132,959 ) $ 99,170 Six Months ended October 31, 2025 Dietary Supplement Segment Consulting Service Segment Total Revenue from external customers: Consulting service income $ $ 10,714 10,714 Sale of dietary supplement products 520,300 520,300 Total revenue 520,300 …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States (GAAP), and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The unaudited condensed consolidated financial statements are presented in US dollars, which is the Companys functional currency. In the opinion of management, the condensed balance sheet as of April 30, 2025 which has been derived from audited consolidated financial statements and these unaudited condensed consolidated financial statements reflect all normal and considered necessary to state fairly the results for the periods presented. The results for the period ended October 31, 2025 are not necessarily indicative of the results to be expected for the entire fiscal year ending April 30, 2026 or for any future period. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Managements Discussion and the audited consolidated financial s …

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

NOTE 10 - SUBSEQUENT EVENTS In accordance with ASC Topic 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after October 31, 2025, up to the date that the unaudited condensed consolidated financial statements were available to be issued. …

SubsequentEventsTextBlock · excerpt; the full note is in the filing